Esophageal Neoplasms: all 1,631 studies
Page 11 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal AdenocarcinomaCompletedNCT03526328
- Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal TumorsStatus unknownNCT03507998Phase 1
- Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerStatus unknownNCT03474341
- Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot StudyCompletedNCT03467529
- Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyCompletedNCT03462524
- European iNvestigation of SUrveillance After Resection for Esophageal CancerCompletedNCT03461341
- Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma SynchronouslyStatus unknownNCT03450447
- Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal CancerTerminatedNCT03437200Phase 2
- OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaCompletedNCT03429816Not applicable
- A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal CancerCompletedNCT03428074
- A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell CancerCompletedNCT03416244Phase 2
- An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal CancerStatus unknownNCT03415815
- Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal CarcinomaCompletedNCT03413436Phase 4
- Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the OesophagusCompletedNCT03410758
- Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal CancersActive, not recruitingNCT03403465Phase 2
- Bispectral Index Throughout Esophageal Cancer OperationCompletedNCT03397745Not applicable
- Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)CompletedNCT03396614
- Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaCompletedNCT03395847Early Phase 1
- Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's OesophagusCompletedNCT03388047Not applicable
- Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous CarcinomaCompletedNCT03381651Not applicable
- The Cohort Study of Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic ResectionStatus unknownNCT03377972
- Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical StudyStatus unknownNCT03368131Phase 2
- Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESCStatus unknownNCT03366883Phase 3
- Pre-operative MRI of Esophagus CancerStatus unknownNCT03347630Not applicable
- Muscle Dysfunction in Gastrointestinal or Hepatobiliary CancerActive, not recruitingNCT03347162
- High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by PropofolCompletedNCT03332433Not applicable
- Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03Status unknownNCT03328234Phase 3
- Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02Status unknownNCT03308552Phase 3
- Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWithdrawnNCT03307941Phase 1/2
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01CompletedNCT03298204
- Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal CancerStatus unknownNCT03286920
- An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and GastricStatus unknownNCT03285906Phase 2/3
- Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial CarcinomaStatus unknownNCT03274349Not applicable
- Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT03274011Phase 2
- Efficacy of Nasogastric Tube Application in Postoperative Care of EsophagectomyStatus unknownNCT03273686Phase 3
- TTS Esophageal HILZO Stent: A Safety and Feasibility StudyStatus unknownNCT03269903Not applicable
- Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal CancerStatus unknownNCT03254511Phase 2
- Determinants of Patient Delay in Doctor Consultation in Oeso-gastric CancersCompletedNCT03246516Not applicable
- trūFreeze® Palliative Esophageal CancerCompletedNCT03243734Not applicable
- Prediction of Lymphatic Metastasis in Esophageal Cancer by CT RadiomicsCompletedNCT03237130
- Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal CancerWithdrawnNCT03234842Phase 2
- Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer PatientsStatus unknownNCT03231462
- Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWithdrawnNCT03220009Phase 2
- A Study of OBP-301 With Radiation Therapy in Patients With Esophageal CancerStatus unknownNCT03213054Phase 1
- Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT03200691Phase 2
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesCompletedNCT03199586Phase 1
- Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal CancerCompletedNCT03187314Phase 2
- The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective InvestigationStatus unknownNCT03176680Not applicable
- Apatinib Treatment for Advanced Esophagus CancerStatus unknownNCT03170310Phase 2
- Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal CancerActive, not recruitingNCT03161535Not applicable
- To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsCompletedNCT03159585Phase 1
- Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerTerminatedNCT03153280Phase 1
- A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATIONCompletedNCT03151642
- An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesTerminatedNCT03144661Phase 1
- Robot-assisted IVOR-LEWIS EsophagectomyStatus unknownNCT03140189
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus CancerCompletedNCT03120572
- PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal CancerCompletedNCT03113214Not applicable
- Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerWithdrawnNCT03110939Not applicable
- Induction Chemotherapy for Locally Advanced Esophageal CancerActive, not recruitingNCT03110926Phase 2
- Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and RecurrenceTerminatedNCT03108885
- Real-time Activity Monitoring to Prevent Admissions During RadioTherapyCompletedNCT03102229Not applicable
- Efficacy of Inspiratory Muscle Training on Respiratory Performance in Patients With Esophageal Cancer Receiving Combined Modality TherapyCompletedNCT03099629Not applicable
- Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by SurgeryCompletedNCT03095209
- Robot-assisted Esophagectomy Versus Conventional Thoracoscopic EsophagectomyStatus unknownNCT03094351Phase 3
- PDL-1 Targeting in Resectable Oesophageal CancerCompletedNCT03087864Phase 2
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- PD-1 Knockout Engineered T Cells for Advanced Esophageal CancerCompletedNCT03081715Not applicable
- The Efficacy and Safety of Caffeic Acid for Esophageal CancerStatus unknownNCT03070262Phase 3
- Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal CancerCompletedNCT03066167
- Endoscopic Resection Multicenter RegistryStatus unknownNCT03065257
- Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal CancerCompletedNCT03057288Not applicable
- Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and LungTerminatedNCT03051802Not applicable
- mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAStatus unknownNCT03045770Not applicable
- Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerActive, not recruitingNCT03044613Phase 1
- Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal NeoplasmCompletedNCT03039608Not applicable
- Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal CancerCompletedNCT03032224
- Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03030937Phase 2
- Biomarkers and Functional Imaging in Predicting Response of Esophageal CancerStatus unknownNCT03029793
- A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerStatus unknownNCT03013712Phase 1/2
- Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal CancerStatus unknownNCT03011255Phase 2
- Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal CancerStatus unknownNCT03005314Not applicable
- Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsStatus unknownNCT03002064Phase 3
- A Study of APR-246 in Oesophageal CancerTerminatedNCT02999893Phase 1/2
- Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01CompletedNCT02979691Phase 2/3
- Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal CancersStatus unknownNCT02970539Phase 1
- Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT02969473Phase 2
- Exercise Prior to OesophagectomyStatus unknownNCT02962219Not applicable
- Different Anesthetic Managements of Esophageal Resection and ReconstructionStatus unknownNCT02961140Not applicable
- A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT02959385Phase 2
- Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal CancerStatus unknownNCT02938195Phase 2
- Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal CancerStatus unknownNCT02937519Phase 2
- Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After EsophagectomyCompletedNCT02937389
- Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal CarcinomaCompletedNCT02911363Not applicable
- Long-term Outcomes of Superficial Esophageal Squamous Cell CarcinomaStatus unknownNCT02908204
- Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal CancerStatus unknownNCT02891083Phase 3
- Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux DiseaseCompletedNCT02890979Not applicable
- Radiochemotherapy in Elderly Patients With Oesophagus CancerCompletedNCT02879227Phase 2
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsActive, not recruitingNCT02869217Phase 1